1. Home
  2. PXLW vs BYSI Comparison

PXLW vs BYSI Comparison

Compare PXLW & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pixelworks Inc.

PXLW

Pixelworks Inc.

HOLD

Current Price

$6.54

Market Cap

39.3M

Sector

Technology

ML Signal

HOLD

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

HOLD

Current Price

$0.75

Market Cap

35.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXLW
BYSI
Founded
1997
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.3M
35.8M
IPO Year
2000
2016

Fundamental Metrics

Financial Performance
Metric
PXLW
BYSI
Price
$6.54
$0.75
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$14.33
N/A
AVG Volume (30 Days)
35.5K
1.9M
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
12.07
N/A
Revenue
$693,000.00
N/A
Revenue This Year
$47.19
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
$0.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.84
$0.67
52 Week High
$15.42
$2.44

Technical Indicators

Market Signals
Indicator
PXLW
BYSI
Relative Strength Index (RSI) 55.34 32.89
Support Level $5.66 N/A
Resistance Level $7.24 $1.84
Average True Range (ATR) 0.39 0.12
MACD 0.05 -0.01
Stochastic Oscillator 55.27 10.60

Price Performance

Historical Comparison
PXLW
BYSI

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Share on Social Networks: